rs11543208
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030930.4(UNC93B1):c.1163C>T(p.Ala388Val) variant causes a missense change. The variant allele was found at a frequency of 0.0159 in 1,546,586 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 20 hom., cov: 29)
Exomes 𝑓: 0.016 ( 186 hom. )
Consequence
UNC93B1
NM_030930.4 missense
NM_030930.4 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 3.75
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004144609).
BP6
Variant 11-67995811-G-A is Benign according to our data. Variant chr11-67995811-G-A is described in ClinVar as [Benign]. Clinvar id is 470488.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0117 (1781/152130) while in subpopulation NFE AF= 0.0172 (1170/67962). AF 95% confidence interval is 0.0164. There are 20 homozygotes in gnomad4. There are 865 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC93B1 | NM_030930.4 | c.1163C>T | p.Ala388Val | missense_variant | Exon 9 of 11 | ENST00000227471.7 | NP_112192.2 | |
UNC93B1 | XM_011545290.1 | c.752C>T | p.Ala251Val | missense_variant | Exon 7 of 9 | XP_011543592.1 | ||
UNC93B1 | XM_011545291.3 | c.608C>T | p.Ala203Val | missense_variant | Exon 6 of 8 | XP_011543593.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0117 AC: 1783AN: 152012Hom.: 21 Cov.: 29
GnomAD3 genomes
AF:
AC:
1783
AN:
152012
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0141 AC: 2054AN: 145576Hom.: 23 AF XY: 0.0146 AC XY: 1146AN XY: 78434
GnomAD3 exomes
AF:
AC:
2054
AN:
145576
Hom.:
AF XY:
AC XY:
1146
AN XY:
78434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0163 AC: 22789AN: 1394456Hom.: 186 Cov.: 36 AF XY: 0.0166 AC XY: 11403AN XY: 687776
GnomAD4 exome
AF:
AC:
22789
AN:
1394456
Hom.:
Cov.:
36
AF XY:
AC XY:
11403
AN XY:
687776
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0117 AC: 1781AN: 152130Hom.: 20 Cov.: 29 AF XY: 0.0116 AC XY: 865AN XY: 74362
GnomAD4 genome
AF:
AC:
1781
AN:
152130
Hom.:
Cov.:
29
AF XY:
AC XY:
865
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
52
ALSPAC
AF:
AC:
63
ESP6500AA
AF:
AC:
10
ESP6500EA
AF:
AC:
81
ExAC
AF:
AC:
542
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
D
Sift4G
Benign
T
Polyphen
B
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at